TIDMEVG

RNS Number : 0150V

Evgen Pharma PLC

08 December 2021

Evgen Pharma plc

("Evgen" or the "Company")

Grant of Options

Evgen Pharma plc (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, announces that, on 8 December 2021, certain employees and directors of the Company, including the following Persons Discharging Managerial Responsibility ("PDMR"), were granted nil cost options (the "Options") over a total of 4,302,975 ordinary shares in the Company exercisable, subject to the Options vesting, for a period of up to 10 years from the date of grant and governed by the rules of the Evgen Pharma plc Long Term Incentive Plan ("LTIP").

 
 PDMR                Position                   Options granted 
 Dr Huw Jones        Chief Executive Officer          1,670,886 
                    -------------------------  ---------------- 
 Richard Moulson     Chief Financial Officer            552,911 
                    -------------------------  ---------------- 
 Dr Glen Clack       Chief Medical Officer              632,911 
                    -------------------------  ---------------- 
 Dr Helen Kuhlman    Chief Business Officer             708,861 
                    -------------------------  ---------------- 
                     Vice President, Project 
 Nick Mallard         Leadership                        612,089 
                    -------------------------  ---------------- 
 

The Options will vest on the third anniversary of grant based on performance against challenging strategic corporate objectives over three years (40%), share price growth (30%) and on an elapsed time basis at 3 years (30%).

Following this award there are 9,786,980 options in issue, representing 3.56% of the Company's issued share capital.

Enquiries:

 
 Evgen Pharma plc www.evgen.com                                          via Walbrook 
 Barry Clare, Chairman 
 Richard Moulson, CFO 
 
 finnCap www.finncap.com                                          +44 (0)20 7220 0500 
 Geoff Nash / Teddy Whiley (Corporate 
  Finance) 
 Alice Lane (ECM) 
 
 Walbrook PR                             +44 (0)20 7933 87870 or evgen@walbrookpr.com 
                                                           + 44 (0)7980 541 893 / +44 
 Paul McManus / Anna Dunphy                                           (0)7876 741 001 
 
 

Notes for editors:

About Evgen Pharma plc

Evgen Pharma is a clinical stage drug development company whose lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. The Company's core technology is Sulforadex(R), a method for synthesising and stabilising the naturally occurring compound sulforaphane and novel proprietary analogues based on sulforaphane. The lead product, SFX-01, is a patented composition of synthetic sulforaphane and alpha-cyclodextrin.

Evgen Pharma commenced operations in January 2008 and has its headquarters at The Colony, Wilmslow, Cheshire, and its registered office is at the Liverpool Science Park, Liverpool. It joined the AIM market of the London Stock Exchange in October 2015 and trades under the ticker symbol EVG.

For further information, please visit: www.evgen.com

For commissioned research on the Company, please visit: http://evgen.com/investors/analyst-coverage/

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 
 1     Details of the person discharging managerial responsibilities/person closely associated 
 a)    Name                                                         Dr Huw Jones 
      -----------------------------------------------------------  --------------------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Position/status                                              Chief Executive 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Initial notification /Amendment                              Initial Notification 
      -----------------------------------------------------------  --------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                         Evgen Pharma Plc 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Legal Entity Identifier                                      213800NO3E6TSTQO8K20 
      -----------------------------------------------------------  --------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of             Options over ordinary shares of 0.25 pence each 
       instrument                                                    GB00BSWYN304 
 
       Identification code 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Nature of the transaction                                    Grant of options 
      -----------------------------------------------------------  --------------------------------------------------- 
 c)    Currency                                                     GBP 
      -----------------------------------------------------------  --------------------------------------------------- 
 d)    Price(s) and volume(s)                                       Price(s)                   Volume(s) 
      -----------------------------------------------------------  -------------------------  ------------------------ 
   nil                                                                                         1,670,886 
  ------------------------------------------------------------------------------------------  ------------------------ 
 
 e)    Aggregated information 
        - Aggregated volume 
        - Price 
        - Aggregated total 
      --------------------------------------------------------------------------------------  ------------------------ 
 f)    Date of the transaction                                      8 December 2021 
      -----------------------------------------------------------  --------------------------------------------------- 
 g)    Place of the transaction                                     London Stock Exchange, AIM 
      -----------------------------------------------------------  --------------------------------------------------- 
 
 
 1     Details of the person discharging managerial responsibilities/person closely associated 
 a)    Name                                                         Richard Moulson 
      -----------------------------------------------------------  --------------------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Position/status                                              Chief Financial Officer 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Initial notification /Amendment                              Initial Notification 
      -----------------------------------------------------------  --------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                         Evgen Pharma plc 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Legal Entity Identifier                                      213800NO3E6TSTQO8K20 
      -----------------------------------------------------------  --------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of             Options over ordinary shares of 0.25 pence each 
       instrument 
                                                                     GB00BSWYN304 
       Identification code 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Nature of the transaction                                    Grant of options 
      -----------------------------------------------------------  --------------------------------------------------- 
 c)    Currency                                                     GBP 
      -----------------------------------------------------------  --------------------------------------------------- 
 d)    Price(s) and volume(s)                                       Price(s)                   Volume(s) 
      -----------------------------------------------------------  -------------------------  ------------------------ 
   nil                                                                                         552,911 
  ------------------------------------------------------------------------------------------  ------------------------ 
 
 e)    Aggregated information 
        - Aggregated volume 
        - Price 
        - Aggregated total 
      --------------------------------------------------------------------------------------  ------------------------ 
 f)    Date of the transaction                                      8 December 2021 
      -----------------------------------------------------------  --------------------------------------------------- 
 g)    Place of the transaction                                     London Stock Exchange, AIM 
      -----------------------------------------------------------  --------------------------------------------------- 
 
 
 1     Details of the person discharging managerial responsibilities/person closely associated 
 a)    Name                                                         Glen Clack 
      -----------------------------------------------------------  --------------------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Position/status                                              Chief Business Officer 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Initial notification /Amendment                              Initial Notification 
      -----------------------------------------------------------  --------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                         Evgen Pharma plc 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Legal Entity Identifier                                      213800NO3E6TSTQO8K20 
      -----------------------------------------------------------  --------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of             Options over ordinary shares of 0.25 pence each 
       instrument 
                                                                     GB00BSWYN304 
       Identification code 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Nature of the transaction                                    Grant of options 
      -----------------------------------------------------------  --------------------------------------------------- 
 c)    Currency                                                     GBP 
      -----------------------------------------------------------  --------------------------------------------------- 
 d)    Price(s) and volume(s)                                       Price(s)                   Volume(s) 
      -----------------------------------------------------------  -------------------------  ------------------------ 
   nil                                                                                         632,911 
  ------------------------------------------------------------------------------------------  ------------------------ 
 
 e)    Aggregated information 
        - Aggregated volume 
        - Price 
        - Aggregated total 
      --------------------------------------------------------------------------------------  ------------------------ 
 f)    Date of the transaction                                      8 December 2021 
      -----------------------------------------------------------  --------------------------------------------------- 
 g)    Place of the transaction                                     London Stock Exchange, AIM 
      -----------------------------------------------------------  --------------------------------------------------- 
 
 
 1     Details of the person discharging managerial responsibilities/person closely associated 
 a)    Name                                                         Helen Kuhlman 
      -----------------------------------------------------------  --------------------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Position/status                                              Chief Business Officer 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Initial notification /Amendment                              Initial Notification 
      -----------------------------------------------------------  --------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                         Evgen Pharma plc 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Legal Entity Identifier                                      213800NO3E6TSTQO8K20 
      -----------------------------------------------------------  --------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of             Options over ordinary shares of 0.25 pence each 
       instrument 
                                                                     GB00BSWYN304 
       Identification code 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Nature of the transaction                                    Grant of options 
      -----------------------------------------------------------  --------------------------------------------------- 
 c)    Currency                                                     GBP 
      -----------------------------------------------------------  --------------------------------------------------- 
 d)    Price(s) and volume(s)                                       Price(s)                   Volume(s) 
      -----------------------------------------------------------  -------------------------  ------------------------ 
   nil                                                                                         708,861 
  ------------------------------------------------------------------------------------------  ------------------------ 
 
 e)    Aggregated information 
        - Aggregated volume 
        - Price 
        - Aggregated total 
      --------------------------------------------------------------------------------------  ------------------------ 
 f)    Date of the transaction                                      8 December 2021 
      -----------------------------------------------------------  --------------------------------------------------- 
 g)    Place of the transaction                                     London Stock Exchange, AIM 
      -----------------------------------------------------------  --------------------------------------------------- 
 
 
 1     Details of the person discharging managerial responsibilities/person closely associated 
 a)    Name                                                         Nick Mallard 
      -----------------------------------------------------------  --------------------------------------------------- 
 2     Reason for the notification 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Position/status                                              VP Project Management 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Initial notification /Amendment                              Initial Notification 
      -----------------------------------------------------------  --------------------------------------------------- 
 3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
        or auction monitor 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Name                                                         Evgen Pharma plc 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Legal Entity Identifier                                      213800NO3E6TSTQO8K20 
      -----------------------------------------------------------  --------------------------------------------------- 
 4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
        each type of transaction; (iii) each date; and (iv) each place where transactions have been 
        conducted 
      ---------------------------------------------------------------------------------------------------------------- 
 a)    Description of the financial instrument, type of             Options over ordinary shares of 0.25 pence each 
       instrument 
                                                                     GB00BSWYN304 
       Identification code 
      -----------------------------------------------------------  --------------------------------------------------- 
 b)    Nature of the transaction                                    Grant of options 
      -----------------------------------------------------------  --------------------------------------------------- 
 c)    Currency                                                     GBP 
      -----------------------------------------------------------  --------------------------------------------------- 
 d)    Price(s) and volume(s)                                       Price(s)                   Volume(s) 
      -----------------------------------------------------------  -------------------------  ------------------------ 
   nil                                                                                         612,089 
  ------------------------------------------------------------------------------------------  ------------------------ 
 
 e)    Aggregated information 
        - Aggregated volume 
        - Price 
        - Aggregated total 
      --------------------------------------------------------------------------------------  ------------------------ 
 f)    Date of the transaction                                      8 December 2021 
      -----------------------------------------------------------  --------------------------------------------------- 
 g)    Place of the transaction                                     London Stock Exchange, AIM 
      -----------------------------------------------------------  --------------------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDKFBKQBDDABK

(END) Dow Jones Newswires

December 08, 2021 09:08 ET (14:08 GMT)

Evgen Pharma (LSE:EVG)
Gráfica de Acción Histórica
De May 2022 a Jun 2022 Haga Click aquí para más Gráficas Evgen Pharma.
Evgen Pharma (LSE:EVG)
Gráfica de Acción Histórica
De Jun 2021 a Jun 2022 Haga Click aquí para más Gráficas Evgen Pharma.